William McKenzie - WaferGen Bio-systems Director
Director
Mr. William McKenzie is Independent Director of Wafergen Biosystems Inc. Mr. McKenzie is a business leader with a strong technical background in nucleic acid purification, immunoassay, genetics and clinical lab medicine with over 25 years of experience building new businesses in the global life sciences and diagnostics sectors. He has served as a senior partner at Upstart Life Science, a management consultancy company, since 2012, and as Vice President and General Manager at Seracare during 2014. Mr. McKenzie held various positions at PerkinElmer from 2005 until 2012, including Business Development Director and Strategic Marketing Director of Molecular Medicine, Global Business Strategist of Genetic Screening, and Vice President and General Manager of Molecular Diagnostics. Prior to that, Mr. McKenzie worked for Millipore in positions of increasing responsibility, most notably as Strategic Marketing Director of Bioscience and General Manager of OEM Healthcare since 2013.
| Age | 62 |
| Tenure | 11 years |
| Phone | 510-651-4450 |
| Web | http://www.wafergen.com |
WaferGen Bio-systems Management Efficiency
The company has return on total asset (ROA) of (90.11) % which means that it has lost $90.11 on every $100 spent on assets. This is way below average. WaferGen Bio-systems' management efficiency ratios could be used to measure how well WaferGen Bio-systems manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 2.94 M in liabilities with Debt to Equity (D/E) ratio of 0.8, which is about average as compared to similar companies. WaferGen Bio systems has a current ratio of 1.78, which is within standard range for the sector. Debt can assist WaferGen Bio-systems until it has trouble settling it off, either with new capital or with free cash flow. So, WaferGen Bio-systems' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like WaferGen Bio systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for WaferGen to invest in growth at high rates of return. When we think about WaferGen Bio-systems' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Walden Rhines | Qorvo Inc | 70 | |
| Ellen Barker | Microchip Technology | 61 | |
| John Marren | Advanced Micro Devices | 55 | |
| Nicholas Donofrio | Advanced Micro Devices | 71 | |
| Wilton Ingram | Integrated Media Technology | N/A | |
| David Ho | Qorvo Inc | 58 | |
| Mark Durcan | Advanced Micro Devices | 57 | |
| James Zug | Amkor Technology | 75 | |
| Con Unerkov | Integrated Media Technology | 55 | |
| John Osborne | Amkor Technology | 71 | |
| Susan Spradley | Qorvo Inc | 57 | |
| Charles Gibson | Qorvo Inc | 65 | |
| Victor Peng | KLA Tencor | 58 | |
| John Dickson | KLA Tencor | 71 | |
| Jeffery Gardner | Qorvo Inc | 57 | |
| Robert Calderoni | KLA Tencor | 58 | |
| Ana Pinczuk | KLA Tencor | 54 | |
| Abhijit Talwalkar | Advanced Micro Devices | 54 | |
| Wai Chow | Advanced Micro Devices | 68 | |
| Walter Wilkinson | Qorvo Inc | 72 | |
| Ahmed Yahia | Advanced Micro Devices | 45 | |
Management Performance
| Return On Asset | -90.11 |
WaferGen Bio systems Leadership Team
Elected by the shareholders, the WaferGen Bio-systems' board of directors comprises two types of representatives: WaferGen Bio-systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of WaferGen. The board's role is to monitor WaferGen Bio-systems' management team and ensure that shareholders' interests are well served. WaferGen Bio-systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, WaferGen Bio-systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Makoto Kaneshiro, Independent Director | ||
| Robert Schueren, Director | ||
| Joel Kanter, Lead Independent Director | ||
| William McKenzie, Director | ||
| Michael Henighan, CFO, Secretary and Treasurer | ||
| Rolland Carlson, CEO and President and Director | ||
| Raymond Hautamaki, Independent Director | ||
| Ivan Trifunovich, Executive Chairman |
WaferGen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is WaferGen Bio-systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -90.11 | |||
| Profit Margin | (175.04) % | |||
| Operating Margin | (171.93) % | |||
| Current Valuation | 16.04 M | |||
| Shares Outstanding | 3.8 M | |||
| Shares Owned By Insiders | 19.50 % | |||
| Shares Owned By Institutions | 5.80 % | |||
| Number Of Shares Shorted | 240.41 K | |||
| Price To Earning | (1.16) X | |||
| Price To Book | 12.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the WaferGen Bio systems information on this page should be used as a complementary analysis to other WaferGen Bio-systems' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in WaferGen Stock
If you are still planning to invest in WaferGen Bio systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WaferGen Bio-systems' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |